SlideShare a Scribd company logo
1 of 3
Abstract
Objective
Methods
Results
Summary and Conclusions•Demonstrate diabetes progression in NOD model
•Investigate DNMT gene expression: RT-PCR
•Investigate DNMT protein level using immunofluorescence
•IPGTT on NOD Mice with Insulin ELISA
•Collection of mRNA and Gene Expression Assay, RT-PCR on DNMT1,
DNMT3A, Ins2 and B-Actin
•Frozen tissue sections of NOD pancreas on slides
•Immunofluorescence and histomorphic analysis using ImageJ of
confocal images: staining for Insulin and DNMT1
•NOD mice exhibit diabetes progression
•Insulin secretion decreased
•DNMT1 and DNMT3A levels increased in the
diabetic group
•DNMT1/3A are elevated and likely contribute to
gene silencing in diabetes; beta cell islet and
immune cells
Methyl
Group Added
by DNMT
DAPI
Insulin
DNMT1
Merge
NOD
Wk8
NOD
Wk12
NOD
Wk16
C57Bl6
Control
Insulin secretion decreased in week 16 (diabetic) group; confirmed by
insulin ELISA and Gene Expression Assay and IF. DNMT1 and DNMT3A
increased in expression, confirmed by gene expression and IF (DNMT1 only)
Healthy
Islets
Diseased
Islets
Immune
Infiltrate
Wk 8-10
Islet
Wk 8-10
Infiltrate
Wk 12-14
Islet
Wk 12-14
Infiltrate
Wk 16
Islet
Wk 16
Infiltrate
Examination of DNA Methyltransferase (DNMT) Levels During the Progression of Type 1
Diabetes
1,2Lauren A. Kenna, 1,2Eitan Akirav, 1Tandra Chakraborty
Image from: Miescher F. 2011.
Controlling Patterns of DNA
Methylation. Medicalpress, Genetics
Type 1 Diabetes (T1D) is defined by an autoimmune destruction of
pancreatic β-cells over time resulting in complete loss of insulin production
and blood glucose regulation. Studies show that many autoimmune
diseases, including diabetes, can be induced by epigenetic changes leading
to insulin deficiency, resistance and glucose intolerance. Epigenetics is the
process by which genes are regulated for expression due to environmental
factors and can directly impact phenotype. These changes are often due to
methylation of DNA, where an enzyme, DNMT, adds a methyl group to a
CpG in gene promoter region to physically block transcription. To examine
the levels; prediabetic and diabetic non-obese diabetic mice (NOD), a
model of human type 1 diabetes, were monitored over a period of 8 weeks;
pancreatic sections and blood samples were obtained to establish the role
of DNMT in islet inflammation. Intraperitoneal Glucose Tolerance Test
(IPGTT) was performed on the day of animal sacrifice to monitor disease
progression with age. DNMT1 expression measured by RT-PCR on whole
pancreatic lysates showed a 3.5 fold increase over time, while insulin gene
expression decreased by ~5 folds in 16 week mice when compared to 8-10
week old animals. DNMT3A increased overall by ~2 fold in expression in
the week 16-diabetic group when compared to the week 8-10 group.
Histomorphic analysis of frozen pancreatic sections stained for DNMT1,
insulin and DAPI showed an increase of 45% in DNMT1 positive area
relative to insulin. This data shows that DNMT1 and DNMT3A is expressed
in higher levels in diabetic pancreatic islets of NOD mice than healthy islets,
suggesting that DNMT1/3A may contribute to gene silencing the islet.
1Adelphi University, Garden City, NY USA, 2Winthrop University Hospital Biomedical Research Institute, Mineola, NY USA
DAPI
Insulin
DNMT1
Merge
NOD
Wk8
NOD
Wk12
NOD
Wk16
C57Bl6
Control
Outline insulin
positive area and
calculate
Transfer outline to
DNMT channel,
calculate positive
nuclei area
Trace infiltrate
area, calculate
positive nuclei
area
Analysis of Immunofluorescence on frozen sections
References
Miescher F. 2011. Controlling Patterns of DNA Methylation. Medicalpress, Genetics. [cited
2016 March 29]. Available from:http://medicalxpress.com/news/2011-10-patterns-dna-
methylation.html
Lienert, F., Wirbelauer, C., Som, I., Dean, A., Mohn, F., & Schübeler, D. (2011).
Identification of genetic elements that autonomously determine DNA methylation
states. Nature genetics, 43(11), 1091-1097.

More Related Content

Viewers also liked (7)

Liz Ibbotson
Liz IbbotsonLiz Ibbotson
Liz Ibbotson
 
Economia teo simo
Economia teo simoEconomia teo simo
Economia teo simo
 
Citas bibliográficas
Citas bibliográficasCitas bibliográficas
Citas bibliográficas
 
Presentacion corso y rueda
Presentacion corso y ruedaPresentacion corso y rueda
Presentacion corso y rueda
 
Corso y rueda
Corso y ruedaCorso y rueda
Corso y rueda
 
THESIS
THESISTHESIS
THESIS
 
Tarea3genetica
Tarea3geneticaTarea3genetica
Tarea3genetica
 

Similar to LK_Adelphi_2016eposter04012016

A reading report for <Obesity-induced DNA hypermethylation of the adiponectin...
A reading report for <Obesity-induced DNA hypermethylation of the adiponectin...A reading report for <Obesity-induced DNA hypermethylation of the adiponectin...
A reading report for <Obesity-induced DNA hypermethylation of the adiponectin...星云 王
 
Insulin blood analysis
Insulin blood analysisInsulin blood analysis
Insulin blood analysisBeshr Nammouz
 
Seminario
SeminarioSeminario
SeminarioIsaupb
 
Seminario Isabel y Luis Carlos
Seminario Isabel y Luis CarlosSeminario Isabel y Luis Carlos
Seminario Isabel y Luis CarlosIsaupb
 
Biologia Molecular
Biologia MolecularBiologia Molecular
Biologia MolecularIsaupb
 
Seminario Biologia molecular Gelena Marsiglia
Seminario Biologia molecular Gelena Marsiglia Seminario Biologia molecular Gelena Marsiglia
Seminario Biologia molecular Gelena Marsiglia GELENAMARSIGLIA
 
Current concept of type 2 DM
Current concept of type 2 DMCurrent concept of type 2 DM
Current concept of type 2 DMDr. Lin
 
special project cyp2e1 report
special project cyp2e1 reportspecial project cyp2e1 report
special project cyp2e1 reportKemal Asik
 
Uromodulin_rs4293393_T_C_variation_is_as.pdf
Uromodulin_rs4293393_T_C_variation_is_as.pdfUromodulin_rs4293393_T_C_variation_is_as.pdf
Uromodulin_rs4293393_T_C_variation_is_as.pdfSeemaNegi34
 
TIRZEPATIDE (COAGONISTA GIP/GP1): DESARROLLO CLINICO SURPASS
TIRZEPATIDE (COAGONISTA GIP/GP1): DESARROLLO CLINICO SURPASSTIRZEPATIDE (COAGONISTA GIP/GP1): DESARROLLO CLINICO SURPASS
TIRZEPATIDE (COAGONISTA GIP/GP1): DESARROLLO CLINICO SURPASSCRISTOBAL MORALES PORTILLO
 
Our Young Research scholars(YRS),Singapore November,2016
Our Young Research scholars(YRS),Singapore November,2016Our Young Research scholars(YRS),Singapore November,2016
Our Young Research scholars(YRS),Singapore November,2016Global R & D Services
 
DIABETES Y ENFERMEDAD CARDIOVASCULAR 23NOVIEMBRE18
DIABETES Y ENFERMEDAD CARDIOVASCULAR   23NOVIEMBRE18 DIABETES Y ENFERMEDAD CARDIOVASCULAR   23NOVIEMBRE18
DIABETES Y ENFERMEDAD CARDIOVASCULAR 23NOVIEMBRE18 CRISTOBAL MORALES PORTILLO
 
Final control diabetes keep up to date 10 march 2016
Final control diabetes keep up to date 10 march 2016Final control diabetes keep up to date 10 march 2016
Final control diabetes keep up to date 10 march 2016alaa wafa
 
GH and IGF Research 2012 OR09-5
GH and IGF Research 2012 OR09-5GH and IGF Research 2012 OR09-5
GH and IGF Research 2012 OR09-5Caroline Nelson
 
Childhood nephrotic syndrome—current and future therapies
Childhood nephrotic syndrome—current and future therapiesChildhood nephrotic syndrome—current and future therapies
Childhood nephrotic syndrome—current and future therapiesnephropdt
 

Similar to LK_Adelphi_2016eposter04012016 (20)

A reading report for <Obesity-induced DNA hypermethylation of the adiponectin...
A reading report for <Obesity-induced DNA hypermethylation of the adiponectin...A reading report for <Obesity-induced DNA hypermethylation of the adiponectin...
A reading report for <Obesity-induced DNA hypermethylation of the adiponectin...
 
Insulin blood analysis
Insulin blood analysisInsulin blood analysis
Insulin blood analysis
 
Seminario
SeminarioSeminario
Seminario
 
Seminario Isabel y Luis Carlos
Seminario Isabel y Luis CarlosSeminario Isabel y Luis Carlos
Seminario Isabel y Luis Carlos
 
Biologia Molecular
Biologia MolecularBiologia Molecular
Biologia Molecular
 
Msd Trivandrum Dr Ka
Msd Trivandrum Dr KaMsd Trivandrum Dr Ka
Msd Trivandrum Dr Ka
 
Seminario Biologia molecular Gelena Marsiglia
Seminario Biologia molecular Gelena Marsiglia Seminario Biologia molecular Gelena Marsiglia
Seminario Biologia molecular Gelena Marsiglia
 
Current concept of type 2 DM
Current concept of type 2 DMCurrent concept of type 2 DM
Current concept of type 2 DM
 
special project cyp2e1 report
special project cyp2e1 reportspecial project cyp2e1 report
special project cyp2e1 report
 
diabetes Mellitus.pptx
diabetes Mellitus.pptxdiabetes Mellitus.pptx
diabetes Mellitus.pptx
 
Uromodulin_rs4293393_T_C_variation_is_as.pdf
Uromodulin_rs4293393_T_C_variation_is_as.pdfUromodulin_rs4293393_T_C_variation_is_as.pdf
Uromodulin_rs4293393_T_C_variation_is_as.pdf
 
TIRZEPATIDE (COAGONISTA GIP/GP1): DESARROLLO CLINICO SURPASS
TIRZEPATIDE (COAGONISTA GIP/GP1): DESARROLLO CLINICO SURPASSTIRZEPATIDE (COAGONISTA GIP/GP1): DESARROLLO CLINICO SURPASS
TIRZEPATIDE (COAGONISTA GIP/GP1): DESARROLLO CLINICO SURPASS
 
Our Young Research scholars(YRS),Singapore November,2016
Our Young Research scholars(YRS),Singapore November,2016Our Young Research scholars(YRS),Singapore November,2016
Our Young Research scholars(YRS),Singapore November,2016
 
Pediatric Pancreatitis - Rivin
Pediatric Pancreatitis - RivinPediatric Pancreatitis - Rivin
Pediatric Pancreatitis - Rivin
 
DIABETES Y ENFERMEDAD CARDIOVASCULAR 23NOVIEMBRE18
DIABETES Y ENFERMEDAD CARDIOVASCULAR   23NOVIEMBRE18 DIABETES Y ENFERMEDAD CARDIOVASCULAR   23NOVIEMBRE18
DIABETES Y ENFERMEDAD CARDIOVASCULAR 23NOVIEMBRE18
 
Final control diabetes keep up to date 10 march 2016
Final control diabetes keep up to date 10 march 2016Final control diabetes keep up to date 10 march 2016
Final control diabetes keep up to date 10 march 2016
 
GH and IGF Research 2012 OR09-5
GH and IGF Research 2012 OR09-5GH and IGF Research 2012 OR09-5
GH and IGF Research 2012 OR09-5
 
Nag diabet nephropatia
Nag diabet nephropatiaNag diabet nephropatia
Nag diabet nephropatia
 
IgA Nephropathy
IgA NephropathyIgA Nephropathy
IgA Nephropathy
 
Childhood nephrotic syndrome—current and future therapies
Childhood nephrotic syndrome—current and future therapiesChildhood nephrotic syndrome—current and future therapies
Childhood nephrotic syndrome—current and future therapies
 

LK_Adelphi_2016eposter04012016

  • 1. Abstract Objective Methods Results Summary and Conclusions•Demonstrate diabetes progression in NOD model •Investigate DNMT gene expression: RT-PCR •Investigate DNMT protein level using immunofluorescence •IPGTT on NOD Mice with Insulin ELISA •Collection of mRNA and Gene Expression Assay, RT-PCR on DNMT1, DNMT3A, Ins2 and B-Actin •Frozen tissue sections of NOD pancreas on slides •Immunofluorescence and histomorphic analysis using ImageJ of confocal images: staining for Insulin and DNMT1 •NOD mice exhibit diabetes progression •Insulin secretion decreased •DNMT1 and DNMT3A levels increased in the diabetic group •DNMT1/3A are elevated and likely contribute to gene silencing in diabetes; beta cell islet and immune cells Methyl Group Added by DNMT DAPI Insulin DNMT1 Merge NOD Wk8 NOD Wk12 NOD Wk16 C57Bl6 Control Insulin secretion decreased in week 16 (diabetic) group; confirmed by insulin ELISA and Gene Expression Assay and IF. DNMT1 and DNMT3A increased in expression, confirmed by gene expression and IF (DNMT1 only) Healthy Islets Diseased Islets Immune Infiltrate Wk 8-10 Islet Wk 8-10 Infiltrate Wk 12-14 Islet Wk 12-14 Infiltrate Wk 16 Islet Wk 16 Infiltrate Examination of DNA Methyltransferase (DNMT) Levels During the Progression of Type 1 Diabetes 1,2Lauren A. Kenna, 1,2Eitan Akirav, 1Tandra Chakraborty Image from: Miescher F. 2011. Controlling Patterns of DNA Methylation. Medicalpress, Genetics Type 1 Diabetes (T1D) is defined by an autoimmune destruction of pancreatic β-cells over time resulting in complete loss of insulin production and blood glucose regulation. Studies show that many autoimmune diseases, including diabetes, can be induced by epigenetic changes leading to insulin deficiency, resistance and glucose intolerance. Epigenetics is the process by which genes are regulated for expression due to environmental factors and can directly impact phenotype. These changes are often due to methylation of DNA, where an enzyme, DNMT, adds a methyl group to a CpG in gene promoter region to physically block transcription. To examine the levels; prediabetic and diabetic non-obese diabetic mice (NOD), a model of human type 1 diabetes, were monitored over a period of 8 weeks; pancreatic sections and blood samples were obtained to establish the role of DNMT in islet inflammation. Intraperitoneal Glucose Tolerance Test (IPGTT) was performed on the day of animal sacrifice to monitor disease progression with age. DNMT1 expression measured by RT-PCR on whole pancreatic lysates showed a 3.5 fold increase over time, while insulin gene expression decreased by ~5 folds in 16 week mice when compared to 8-10 week old animals. DNMT3A increased overall by ~2 fold in expression in the week 16-diabetic group when compared to the week 8-10 group. Histomorphic analysis of frozen pancreatic sections stained for DNMT1, insulin and DAPI showed an increase of 45% in DNMT1 positive area relative to insulin. This data shows that DNMT1 and DNMT3A is expressed in higher levels in diabetic pancreatic islets of NOD mice than healthy islets, suggesting that DNMT1/3A may contribute to gene silencing the islet. 1Adelphi University, Garden City, NY USA, 2Winthrop University Hospital Biomedical Research Institute, Mineola, NY USA
  • 2. DAPI Insulin DNMT1 Merge NOD Wk8 NOD Wk12 NOD Wk16 C57Bl6 Control Outline insulin positive area and calculate Transfer outline to DNMT channel, calculate positive nuclei area Trace infiltrate area, calculate positive nuclei area Analysis of Immunofluorescence on frozen sections
  • 3. References Miescher F. 2011. Controlling Patterns of DNA Methylation. Medicalpress, Genetics. [cited 2016 March 29]. Available from:http://medicalxpress.com/news/2011-10-patterns-dna- methylation.html Lienert, F., Wirbelauer, C., Som, I., Dean, A., Mohn, F., & Schübeler, D. (2011). Identification of genetic elements that autonomously determine DNA methylation states. Nature genetics, 43(11), 1091-1097.